FDA Gives Nod to Lucentis for Diabetic Eye Disease
14:08 EDT 10 Aug 2012 | Drugs.com
FRIDAY, Aug. 10 -- The U.S. Food and Drug Administration on Friday gave its approval to the drug Lucentis as a treatment for diabetic macular edema (DME), making it the first medicine approved for the ailment. According to the U.S. Centers for...
Original Article: FDA Gives Nod to Lucentis for Diabetic Eye Disease
More From BioPortfolio on "FDA Gives Nod to Lucentis for Diabetic Eye Disease"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
